Skip to content

Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening

Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04557423
Enrollment
797
Registered
2020-09-21
Start date
2021-04-08
Completion date
2025-11-30
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Neoplasms

Brief summary

This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Asian American (Korean, Vietnamese, and Chinese) women. All women will receive an educational program and navigation assistance. Women in the intervention condition will also receive a self-sampling kit for self-collection of a cervical sample for HPV testing. The investigators will evaluate whether the inclusion of a self-sampling kit increases the proportion of Asian American women who participate in cervical cancer screening.

Detailed description

Aim 1: Compare rates of providing a self-collected sample vs. obtaining clinic-based screening among 1100 Asian American women. It is hypothesized that the proportion of women in the HPV self-sampling program who provide a self-collected sample will be higher than the proportion of women in the clinic-based program who obtain clinic-based screening. Aim 2: Examine mediators of participation. The investigators will examine both individual- and social/environmental-level factors associated with participation across both programs. It is hypothesized that higher levels of perceived self-efficacy, lower levels of embarrassment, and fewer barriers will be associated with higher rates of participation in both conditions. Further, it is hypothesized that women in the HPV self-sampling program will report greater self-efficacy, less embarrassment, and fewer barriers compared to women in the clinic-based program. Aim 3: Assess the relative cost-effectiveness of HPV self-sampling vs. clinic-based screening. The investigators will conduct an incremental cost-effectiveness analysis from a societal perspective incorporating trial-based direct medical and participant-borne costs associated with HPV self-sampling vs. clinic-based screening. It is hypothesized that the self-sampling program will be less costly to implement and achieve a higher participation rate.

Interventions

BEHAVIORALCommunity-Based Education

A previously evaluated educational intervention delivered in community settings. Includes culturally- and linguistically-appropriate materials.

BEHAVIORALNavigation to Screening

Community health educators provide navigation assistance to access clinic-based cervical cancer screening.

An HPV self-sampling kit will be provided for home-based collection of cervical samples. Samples will be sent for analysis of HPV subtypes.

Sponsors

Fox Chase Cancer Center
Lead SponsorOTHER
Temple University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Women who are of Asian race and self-identify as Korean, Vietnamese, or Chinese * are 30-65 years of age * are overdue for cervical cancer screening (e.g., no cytology-based screening within the past 3 years; no hrHPV testing either alone or in combination with cytology in the past 5 years)

Exclusion criteria

* have a prior diagnosis of cervical cancer or cervical abnormality (e.g., dysplasia) * had a hysterectomy with removal of the cervix * have a compromised immune system (e.g., known HIV) * unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Participation in screening6 monthsThe number of women who obtain clinic-based screening or return a self-collected sample

Secondary

MeasureTime frameDescription
Program delivery cost6 monthsThe costs associated with delivering each program. This will include: (1) Participant costs (time spent participating in educational sessions and time required to complete screening; transportation costs, if incurred); (2) Screening costs (cost of clinic-based screening, or cost of the HPV self-sampling kit); (3) Program delivery costs (community health educator time for conducting the educational programs, time will be valued at wage rates including benefits; costs of educational materials \[flyers, booklets\] and reminder letters); (4) Navigation costs (time and labor involved in navigating women to the clinic for screening will be documented using a log of CHE time and expenses incurred).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCarolyn Y Fang, PhD

Fox Chase Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026